Ventana PD-L1 (SP142) Assay Reagent for Immunohistochemical Assessment of Programmed Death Ligand-1 Protein in In Vitro Diagnostics

Ventana PD-L1 (SP142) Assay Reagent for Immunohistochemical Assessment of Programmed Death Ligand-1 Protein in In Vitro Diagnostics

The Ventana PD-L1 (SP142) Assay reagent is specifically designed for the immunohistochemical evaluation of Programmed Death Ligand-1 (PD-L1) protein in in vitro diagnostics. It is intended for use with Ventana BenchMark automatic immunostainers.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Ventana PD-L1 (SP142) Assay Reagent for Immunohistochemical Assessment of Programmed Death Ligand-1 Protein in In Vitro Diagnostics, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.